Jun 25, 2025
The B-cell lymphoma market reached a value of USD 5.0 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 9.2 Billion by 2035.
Jun 20, 2025
The 7 major chronic sialorrhea markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.15% during 2024-2034.
Jun 13, 2025
The acute lymphoblastic leukemia market reached a value of USD 2,270.5 Million across the top 7 markets (US, EU4, UK, and Japan) in 2024.
Jun 12, 2025
The top 7 (US, EU4, UK, and Japan) advanced pancreatic cancer markets are expected to exhibit a CAGR of 5.56% during 2025-2035.
Jun 09, 2025
The 7 major gastroesophageal reflux disease markets reached a value of USD 5.1 Billion in 2024.
Jun 06, 2025
The down syndrome market reached a value of USD 1.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024.
Jun 05, 2025
The 7 major hypertrophic cardiomyopathy markets reached a value of US$ 312.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 356.7 Million by 2034, exhibiting a growth rate (CAGR) of 1.21% during 2024-2034..
Jun 02, 2025
TThe 7 major valley fever markets reached a value of USD 717.46 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1,046.45 Million by 2035.
May 30, 2025
The 7 major uveal melanoma markets reached a value of USD 1,000 Million in 2024.
May 26, 2025
The generalized anxiety disorder market reached a value of USD 1.9 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2024.